<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33078197</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1744-1358</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>26</Day></PubDate></JournalIssue><Title>Essays in biochemistry</Title><ISOAbbreviation>Essays Biochem</ISOAbbreviation></Journal><ArticleTitle>The role of DNA damage response in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>847</StartPage><EndPage>861</EndPage><MedlinePgn>847-861</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1042/EBC20200002</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a rapidly disabling and fatal neurodegenerative disease. Due to insufficient disease-modifying treatments, there is an unmet and urgent need for elucidating disease mechanisms that occur early and represent common triggers in both familial and sporadic ALS. Emerging evidence suggests that impaired DNA damage response contributes to age-related somatic accumulation of genomic instability and can trigger or accelerate ALS pathological manifestations. In this review, we summarize and discuss recent studies indicating a direct link between DNA damage response and ALS. Further mechanistic understanding of the role genomic instability is playing in ALS disease pathophysiology will be critical for discovering new therapeutic avenues.</AbstractText><CopyrightInformation>&#xa9; 2020 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at University of Cambridge, Cambridge CB2 0AH, U.K.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0AH, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curle</LastName><ForeName>Annabel J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at University of Cambridge, Cambridge CB2 0AH, U.K.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0AH, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haider</LastName><ForeName>Arshad M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at University of Cambridge, Cambridge CB2 0AH, U.K.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0AH, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balmus</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at University of Cambridge, Cambridge CB2 0AH, U.K.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0AH, U.K.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Essays Biochem</MedlineTA><NlmUniqueID>0043306</NlmUniqueID><ISSNLinking>0071-1365</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA damage response</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Genome instability</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Repeat expansion</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword></KeywordList><CoiStatement>G.B. is a co-founder and consultant for Adrestia Therapeutics Ltd. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33078197</ArticleId><ArticleId IdType="pmc">PMC7588667</ArticleId><ArticleId IdType="doi">10.1042/EBC20200002</ArticleId><ArticleId IdType="pii">226703</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>del Aguila M.A., Longstreth W.T., McGuire V., Koepsell T.D. and van Belle G. (2003) Prognosis in amyotrophic lateral sclerosis: A population-based study. Neurology 60, 813&#x2013;819</Citation><ArticleIdList><ArticleId IdType="pubmed">12629239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W. et al. . (2017) Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers 3, 17071 10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur K.C., Calvo A., Price T.R., Geiger J.T., Chi&#xf2; A. and Traynor B.J. (2016) Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat. Commun. 7, 12408 10.1038/ncomms12408</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Bastida J., Perestelo-P&#xe9;rez L., Mont&#xf3;n-Alvarez F., Serrano-Aguilar P. and Alfonso-Sanchez J.L. (2009) Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain. Amyotroph Lateral Scler Off. Publ. World Fed Neurol. Res Group Mot. Neuron. Dis. 10, 237&#x2013;243</Citation><ArticleIdList><ArticleId IdType="pubmed">18821088</ArticleId></ArticleIdList></Reference><Reference><Citation>Schepelmann K., Winter Y., Spottke A.E., Claus D., Grothe C., Schr&#xf6;der R. et al. . (2009) Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J. Neurol. 257, 15&#x2013;23 10.1007/s00415-009-5256-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5256-6</ArticleId><ArticleId IdType="pubmed">19629566</ArticleId></ArticleIdList></Reference><Reference><Citation>Kordower J.H., Olanow C.W., Dodiya H.B., Chu Y., Beach T.G., Adler C.H. et al. . (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain J. Neurol. 136, 2419&#x2013;2431 10.1093/brain/awt192</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt192</ArticleId><ArticleId IdType="pmc">PMC3722357</ArticleId><ArticleId IdType="pubmed">23884810</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrag A., Horsfall L., Walters K., Noyce A. and Petersen I. (2015) Prediagnostic presentations of Parkinson's disease in primary care: a case-control study. Lancet Neurol. 14, 57&#x2013;64 10.1016/S1474-4422(14)70287-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70287-X</ArticleId><ArticleId IdType="pubmed">25435387</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C.R., Knopman D.S., Jagust W.J., Petersen R.C., Weiner M.W., Aisen P.S. et al. . (2013) Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207&#x2013;216 10.1016/S1474-4422(12)70291-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70291-0</ArticleId><ArticleId IdType="pmc">PMC3622225</ArticleId><ArticleId IdType="pubmed">23332364</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabrizi S.J., Reilmann R., Roos R.A., Durr A., Leavitt B., Owen G. et al. . (2012) Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol. 11, 42&#x2013;53 10.1016/S1474-4422(11)70263-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70263-0</ArticleId><ArticleId IdType="pubmed">22137354</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A., Kiernan M., Mitsumoto H. and Swash M. (2014) Amyotrophic lateral sclerosis: a long preclinical period? J. Neurol. Neurosurg. Psychiatry 85, 1232&#x2013;1238 10.1136/jnnp-2013-307135</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307135</ArticleId><ArticleId IdType="pubmed">24648037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W. et al. . (2017) Correction: Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers 3, 17085 10.1038/nrdp.2017.85</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H. et al. . (2017) Amyotrophic lateral sclerosis. Lancet 390, 2084&#x2013;2098 10.1016/S0140-6736(17)31287-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A. and Traynor B.J. (2013) State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17, 17&#x2013;23 10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B.N., Topp S.D., Fallini C., Shibata H., Chen H.-J., Troakes C. et al. . (2017) Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci. Transl. Med. 9, eaad9157 10.1126/scitranslmed.aad9157</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aad9157</ArticleId><ArticleId IdType="pmc">PMC6599403</ArticleId><ArticleId IdType="pubmed">28469040</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Nicholson A.M., Sarkar M., Messing J., Purice M.D., Pottier C. et al. . (2017) TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron 95, 808.e9&#x2013;816.e9 10.1016/j.neuron.2017.07.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Moll T., Ramesh T., Castelli L., Beer A., Robins H. et al. . (2019) Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral Sclerosis. Cell Rep. 26, 2298.e5&#x2013;2306.e5 10.1016/j.celrep.2019.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.02.006</ArticleId><ArticleId IdType="pmc">PMC7003067</ArticleId><ArticleId IdType="pubmed">30811981</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C. and El-Khamisy S.F. (2018) Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementia. Brain 141, 1247&#x2013;1262 10.1093/brain/awy076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy076</ArticleId><ArticleId IdType="pmc">PMC5917746</ArticleId><ArticleId IdType="pubmed">29584802</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R. and Isaacs A.M. (2018) C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 14, 544&#x2013;558 10.1038/s41582-018-0047-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C. and Saxena S. (2017) ER stress and the unfolded protein response in neurodegeneration. Nat. Rev. Neurol. 13, 477&#x2013;491 10.1038/nrneurol.2017.99</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.99</ArticleId><ArticleId IdType="pubmed">28731040</ArticleId></ArticleIdList></Reference><Reference><Citation>Paez-Colasante X., Figueroa-Romero C., Sakowski S.A., Goutman S.A. and Feldman E.L. (2015) Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat. Rev. Neurol. 11, 266&#x2013;279 10.1038/nrneurol.2015.57</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.57</ArticleId><ArticleId IdType="pubmed">25896087</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Polymenidou M. and Cleveland D.W. (2013) Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis. Neuron 79, 416&#x2013;438 10.1016/j.neuron.2013.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Madabhushi R., Pan L. and Tsai L.-H. (2014) DNA Damage and Its Links to Neurodegeneration. Neuron 83, 266&#x2013;282 10.1016/j.neuron.2014.06.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.06.034</ArticleId><ArticleId IdType="pmc">PMC5564444</ArticleId><ArticleId IdType="pubmed">25033177</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson S.P. and Bartek J. (2009) The DNA-damage response in human biology and disease. Nature 461, 1071&#x2013;1078 10.1038/nature08467</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08467</ArticleId><ArticleId IdType="pmc">PMC2906700</ArticleId><ArticleId IdType="pubmed">19847258</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiuri T., Suart C.E., Hung C.L.K., Graham K.J., Bazan C.A.B. and Truant R. (2019) DNA Damage Repair in Huntington&#x2019;s Disease and Other Neurodegenerative Diseases. Neurotherapeutics 16, 948&#x2013;956 10.1007/s13311-019-00768-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-019-00768-7</ArticleId><ArticleId IdType="pmc">PMC6985310</ArticleId><ArticleId IdType="pubmed">31364066</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu T., Pan Y., Kao S.-Y., Li C., Kohane I., Chan J. et al. . (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429, 883&#x2013;891 10.1038/nature02661</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02661</ArticleId><ArticleId IdType="pubmed">15190254</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K., Ikuno Y., Kakeya Y., Ikeno S., Taniura H., Kurono M. et al. . (2019) Age-related dysfunction of the DNA damage response in intestinal stem cells. Inflamm. Regen. 39, 8 10.1186/s41232-019-0096-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41232-019-0096-y</ArticleId><ArticleId IdType="pmc">PMC6485179</ArticleId><ArticleId IdType="pubmed">31057688</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackford A.N. and Jackson S.P. (2017) ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response. Mol. Cell 66, 801&#x2013;817 10.1016/j.molcel.2017.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.05.015</ArticleId><ArticleId IdType="pubmed">28622525</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccia A. and Elledge S.J. (2010) The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179&#x2013;204 10.1016/j.molcel.2010.09.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.09.019</ArticleId><ArticleId IdType="pmc">PMC2988877</ArticleId><ArticleId IdType="pubmed">20965415</ArticleId></ArticleIdList></Reference><Reference><Citation>Welty S., Teng Y., Liang Z., Zhao W., Sanders L.H., Greenamyre J.T. et al. . (2017) RAD52 is required for RNA-templated recombination repair in post-mitotic neurons. J. Biol. Chem. 293, 1353&#x2013;1362 10.1074/jbc.M117.808402</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.808402</ArticleId><ArticleId IdType="pmc">PMC5787811</ArticleId><ArticleId IdType="pubmed">29217771</ArticleId></ArticleIdList></Reference><Reference><Citation>Frade J.M. and Ovejero-Benito M.C. (2015) Neuronal cell cycle: the neuron itself and its circumstances. Cell Cycle 14, 712&#x2013;720 10.1080/15384101.2015.1004937</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2015.1004937</ArticleId><ArticleId IdType="pmc">PMC4418291</ArticleId><ArticleId IdType="pubmed">25590687</ArticleId></ArticleIdList></Reference><Reference><Citation>de Anda F.C., Madabhushi R., Rei D., Meng J., Gr&#xe4;ff J., Durak O. et al. . (2016) Cortical neurons gradually attain a post-mitotic state. Cell Res. 26, 1033&#x2013;1047</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5034108</ArticleId><ArticleId IdType="pubmed">27325298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Dan X., Babbar M., Wei Y., Hasselbalch S.G., Croteau D.L. et al. . (2019) Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 15, 565&#x2013;581 10.1038/s41582-019-0244-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A. et al. . (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59&#x2013;62 10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J., Guerrero E.N., Hegde P.M., Liachko N.F., Wang H., Vasquez V. et al. . (2019) Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc. Natl. Acad. Sci. 116, 4696&#x2013;4705 10.1073/pnas.1818415116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818415116</ArticleId><ArticleId IdType="pmc">PMC6410842</ArticleId><ArticleId IdType="pubmed">30770445</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.-Y., Pan L., Su S.C., Quinn E.J., Sasaki M., Jimenez J.C. et al. . (2013) Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat. Neurosci. 16, 1383&#x2013;1391 10.1038/nn.3514</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3514</ArticleId><ArticleId IdType="pmc">PMC5564396</ArticleId><ArticleId IdType="pubmed">24036913</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O. et al. . (2011) Amyotrophic lateral sclerosis. Lancet 377, 942&#x2013;955 10.1016/S0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridovich I. (1997) Superoxide Anion Radical (O&#xb7;&#x304; 2), Superoxide Dismutases, and Related Matters. J. Biol. Chem. 272, 18515&#x2013;18517 10.1074/jbc.272.30.18515</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.30.18515</ArticleId><ArticleId IdType="pubmed">9228011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Cova E., Davin A., Guareschi S., Abel K., Alvisi E. et al. . (2010) SOD1 mRNA expression in sporadic amyotrophic lateral sclerosis. Neurobiol. Dis. 39, 198&#x2013;203 10.1016/j.nbd.2010.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.04.008</ArticleId><ArticleId IdType="pubmed">20399857</ArticleId></ArticleIdList></Reference><Reference><Citation>Canugovi C., Misiak M., Ferrarelli L.K., Croteau D.L. and Bohr V.A. (2013) The role of DNA repair in brain related disease pathology. DNA Repair (Amst.) 12, 578&#x2013;587 10.1016/j.dnarep.2013.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2013.04.010</ArticleId><ArticleId IdType="pmc">PMC3720728</ArticleId><ArticleId IdType="pubmed">23721970</ArticleId></ArticleIdList></Reference><Reference><Citation>Slupphaug G., Kavli B. and Krokan H.E. (2003) The interacting pathways for prevention and repair of oxidative DNA damage. Mutat. Res. Fundam. Mol. Mech. Mutagen. 531, 231&#x2013;251 10.1016/j.mrfmmm.2003.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrfmmm.2003.06.002</ArticleId><ArticleId IdType="pubmed">14637258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P. and Rouleau G.A. (2007) Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis? Ann. Neurol. 62, 553&#x2013;559 10.1002/ana.21319</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21319</ArticleId><ArticleId IdType="pubmed">18074357</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiloh Y. and Ziv Y. (2013) The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol. 14, 197&#x2013;210 10.1038/nrm3546</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3546</ArticleId><ArticleId IdType="pubmed">23486281</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang C.K., Liu Y., Thomas J., Zhang Y. and Zheng X.F.S. (2014) Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nat. Commun. 5, 3446 10.1038/ncomms4446</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4446</ArticleId><ArticleId IdType="pmc">PMC4678626</ArticleId><ArticleId IdType="pubmed">24647101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X.-D., Zhu M.-W., Shan D., Wang S.-Y., Yin X., Yang Y.-Q. et al. . (2019) Spy1, a unique cell cycle regulator, alters viability in ALS motor neurons and cell lines in response to mutant SOD1-induced DNA damage. DNA Repair (Amst.) 74, 51&#x2013;62 10.1016/j.dnarep.2018.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2018.12.005</ArticleId><ArticleId IdType="pubmed">30630676</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter L.A., Kong-Beltran M. and Donoghue D.J. (2003) Spy1 Interacts with p27 Kip1 to Allow G 1 /S Progression. Mol. Biol. Cell 14, 3664&#x2013;3674 10.1091/mbc.e02-12-0820</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e02-12-0820</ArticleId><ArticleId IdType="pmc">PMC196558</ArticleId><ArticleId IdType="pubmed">12972555</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye W. and Blain S.W. (2010) S phase entry causes homocysteine-induced death while ataxia telangiectasia and Rad3 related protein functions anti-apoptotically to protect neurons. Brain J. Neurol. 133, 2295&#x2013;2312 10.1093/brain/awq139</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq139</ArticleId><ArticleId IdType="pmc">PMC3139932</ArticleId><ArticleId IdType="pubmed">20639548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruman I.I., Wersto R.P., Cardozo-Pelaez F., Smilenov L., Chan S.L., Chrest F.J. et al. . (2004) Cell Cycle Activation Linked to Neuronal Cell Death Initiated by DNA Damage. Neuron 41, 549&#x2013;561 10.1016/S0896-6273(04)00017-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(04)00017-0</ArticleId><ArticleId IdType="pubmed">14980204</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X., Lin H., Wang X., Zuo Q., Qin J. and Zhang P. (2015) The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair. Acta Bioch. Bioph. Sin. 47, 834&#x2013;841 10.1093/abbs/gmv076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmv076</ArticleId><ArticleId IdType="pmc">PMC4581587</ArticleId><ArticleId IdType="pubmed">26290490</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelegrini A.L., Moura D.J., Brenner B.L., Ledur P.F., Maques G.P., Henriques J.A.P. et al. . (2010) Nek1 silencing slows down DNA repair and blocks DNA damage-induced cell cycle arrest. Mutagenesis 25, 447&#x2013;454 10.1093/mutage/geq026</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mutage/geq026</ArticleId><ArticleId IdType="pubmed">20501547</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Liu P., Inuzuka H. and Wei W. (2014) Roles of F-box proteins in cancer. Nat. Rev. Cancer 14, 233&#x2013;247 10.1038/nrc3700</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3700</ArticleId><ArticleId IdType="pmc">PMC4306233</ArticleId><ArticleId IdType="pubmed">24658274</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai C., Richman R. and Elledge S.J. (1994) Human cyclin F. EMBO J. 13, 6087&#x2013;6098 10.1002/j.1460-2075.1994.tb06955.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1994.tb06955.x</ArticleId><ArticleId IdType="pmc">PMC395587</ArticleId><ArticleId IdType="pubmed">7813445</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen-Plotkin A.S., Lee V.M.-Y. and Trojanowski J.Q. (2010) TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 6, 211&#x2013;220 10.1038/nrneurol.2010.18</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.18</ArticleId><ArticleId IdType="pmc">PMC2892118</ArticleId><ArticleId IdType="pubmed">20234357</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton M.J., Igaz L.M., Wong M.M., Kwong L.K., Trojanowski J.Q. and Lee V.M.-Y. (2008) Disturbance of Nuclear and Cytoplasmic TAR DNA-binding Protein (TDP-43) Induces Disease-like Redistribution, Sequestration, and Aggregate Formation. J. Biol. Chem. 283, 13302&#x2013;13309 10.1074/jbc.M800342200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz L.M., Kwong L.K., Xu Y., Truax A.C., Uryu K., Neumann M. et al. . (2008) Enrichment of C-Terminal Fragments in TAR DNA-Binding Protein-43 Cytoplasmic Inclusions in Brain but not in Spinal Cord of Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Am. J. Pathol. 173, 182&#x2013;194 10.2353/ajpath.2008.080003</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.080003</ArticleId><ArticleId IdType="pmc">PMC2438296</ArticleId><ArticleId IdType="pubmed">18535185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C. and Cleveland D.W. (2009) Rethinking ALS: the FUS about TDP-43. Cell 136, 1001&#x2013;1004 10.1016/j.cell.2009.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.03.006</ArticleId><ArticleId IdType="pmc">PMC3110083</ArticleId><ArticleId IdType="pubmed">19303844</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P., Sidle K.C.L. and Hardy J. (2015) Review: Prion-like mechanisms of transactive response DNA binding protein of 43&#x2009;kDa (TDP-43) in amyotrophic lateral sclerosis (ALS). Neuropath. Appl. Neurol. 41, 578&#x2013;597 10.1111/nan.12206</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12206</ArticleId><ArticleId IdType="pubmed">25487060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer R.C., Chami A.A., de Assis D.R., Vourc'h P., Andres C.R., Corcia P. et al. . (2019) The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight? Brain 142, 1176&#x2013;1194 10.1093/brain/awz078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz078</ArticleId><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L. and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. 82, 4245&#x2013;4249 10.1073/pnas.82.12.4245</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.82.12.4245</ArticleId><ArticleId IdType="pmc">PMC397973</ArticleId><ArticleId IdType="pubmed">3159021</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini M.G., Schmidt M.L., Lee V.M.-Y., Trojanowski J.Q., Jakes R. and Goedert M. (1997) &#x3b1;-Synuclein in Lewy bodies. Nature 388, 839&#x2013;840 10.1038/42166</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/42166</ArticleId><ArticleId IdType="pubmed">9278044</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A. et al. . (1997) Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation. Cell 90, 537&#x2013;548 10.1016/S0092-8674(00)80513-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80513-9</ArticleId><ArticleId IdType="pubmed">9267033</ArticleId></ArticleIdList></Reference><Reference><Citation>DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P. et al. . (1997) Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain. Science 277, 1990&#x2013;1993 10.1126/science.277.5334.1990</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.277.5334.1990</ArticleId><ArticleId IdType="pubmed">9302293</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Deng J., Dong J., Liu J., Bigio E.H., Mesulam M. et al. . (2019) TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 15, e1007947 10.1371/journal.pgen.1007947</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero E.N., Mitra J., Wang H., Rangaswamy S., Hegde P.M., Basu P. et al. . (2019) Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. Hum. Mol. Genet. 28, 2459&#x2013;2476 10.1093/hmg/ddz062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz062</ArticleId><ArticleId IdType="pmc">PMC6659010</ArticleId><ArticleId IdType="pubmed">31067307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang L., Lu J., Siedlak S.L., Fujioka H., Liang J. et al. . (2016) The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 22, 869&#x2013;878 10.1038/nm.4130</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham K.J., Chan J.N.Y., Salvi J.S., Ho B., Hall A., Vidya E. et al. . (2016) Intersection of calorie restriction and magnesium in the suppression of genome-destabilizing RNA-DNA hybrids. Nucleic Acids Res. 44, 8870&#x2013;8884 10.1093/nar/gkw752</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw752</ArticleId><ArticleId IdType="pmc">PMC5063000</ArticleId><ArticleId IdType="pubmed">27574117</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.-J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X. et al. . (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466, 1069&#x2013;1075 10.1038/nature09320</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Hu W., Tan X., Qu S., Chu D., Gong C.-X. et al. . (2019) Elevation of casein kinase 1&#x3b5; associated with TDP-43 and tau pathologies in Alzheimer's disease. Brain Pathol. Zurich Switz 30, 283&#x2013;297 10.1111/bpa.12775</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12775</ArticleId><ArticleId IdType="pubmed">31376192</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippschild U., Kr&#xfc;ger M., Richter J., Xu P., Garc&#xed;a-Reyes B., Peifer C. et al. . (2014) The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis. Front. Oncol. 4, 96 10.3389/fonc.2014.00096</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2014.00096</ArticleId><ArticleId IdType="pmc">PMC4032983</ArticleId><ArticleId IdType="pubmed">24904820</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Boom J., Wolf M., Weimann L., Schulze N., Li F., Kaschani F. et al. . (2016) VCP/p97 Extracts Sterically Trapped Ku70/80 Rings from DNA in Double-Strand Break Repair. Mol. Cell 64, 189&#x2013;198 10.1016/j.molcel.2016.08.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.08.037</ArticleId><ArticleId IdType="pmc">PMC5161236</ArticleId><ArticleId IdType="pubmed">27716483</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt G., Carroll B., Sarallah R., Correia-Melo C., Ogrodnik M., Nelson G. et al. . (2016) SQSTM1/p62 mediates crosstalk between autophagy and the UPS in DNA repair. Autophagy 12, 1917&#x2013;1930 10.1080/15548627.2016.1210368</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1210368</ArticleId><ArticleId IdType="pmc">PMC5391493</ArticleId><ArticleId IdType="pubmed">27391408</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A.N., Oehler J., Torrecilla I., Kilgas S., Li S., Vaz B. et al. . (2019) The p97-Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF 8. EMBO J. 38, e102361 10.15252/embj.2019102361</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019102361</ArticleId><ArticleId IdType="pmc">PMC6826192</ArticleId><ArticleId IdType="pubmed">31613024</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmus G., Barros A.C., Wijnhoven P.W.G., Lescale C., Hasse H.L., Boroviak K. et al. . (2016) Synthetic lethality between PAXX and XLF in mammalian development. Gene. Dev. 30, 2152&#x2013;2157 10.1101/gad.290510.116</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.290510.116</ArticleId><ArticleId IdType="pmc">PMC5088564</ArticleId><ArticleId IdType="pubmed">27798842</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev H., Chiang T.-W.W., Lescale C., de Krijger I., Martin A.G., Pilger D. et al. . (2018) Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells. Nat. Cell Biol. 20, 954&#x2013;965 10.1038/s41556-018-0140-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0140-1</ArticleId><ArticleId IdType="pmc">PMC6145444</ArticleId><ArticleId IdType="pubmed">30022119</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill S.J., Mordes D.A., Cameron L.A., Neuberg D.S., Landini S., Eggan K. et al. . (2016) Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proc. Natl. Acad. Sci. 113, E7701&#x2013;E7709 10.1073/pnas.1611673113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1611673113</ArticleId><ArticleId IdType="pmc">PMC5137757</ArticleId><ArticleId IdType="pubmed">27849576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A. and Buratti E. (2016) Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 138, 95&#x2013;111 10.1111/jnc.13625</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero E.N., Wang H., Mitra J., Hegde P.M., Stowell S.E., Liachko N.F. et al. . (2016) TDP-43/FUS in motor neuron disease: Complexity and challenges. Prog. Neurobiol. 145&#x2013;146, 78&#x2013;97 10.1016/j.pneurobio.2016.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.09.004</ArticleId><ArticleId IdType="pmc">PMC5101148</ArticleId><ArticleId IdType="pubmed">27693252</ArticleId></ArticleIdList></Reference><Reference><Citation>Crozat A., &#xc5;man P., Mandahl N. and Ron D. (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 640&#x2013;644 10.1038/363640a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/363640a0</ArticleId><ArticleId IdType="pubmed">8510758</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbitts T.H., Forster A., Larson R. and Nathan P. (1993) Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat. Genet. 4, 175&#x2013;180 10.1038/ng0693-175</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0693-175</ArticleId><ArticleId IdType="pubmed">7503811</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortobagyi T., Vos K.J.D., Nishimura A.L., Sreedharan J. et al. . (2009) Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6. Science 323, 1208&#x2013;1211 10.1126/science.1165942</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y. et al. . (2015) A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell 162, 1066&#x2013;1077 10.1016/j.cell.2015.07.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrocola A.S., Kim S.H., Trinh A.T., Rodenkirch L.A. and Tibbetts R.S. (2013) The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage. J. Biol. Chem. 288, 24731&#x2013;24741 10.1074/jbc.M113.497974</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.497974</ArticleId><ArticleId IdType="pmc">PMC3750169</ArticleId><ArticleId IdType="pubmed">23833192</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Rangaswamy S., Kodavati M., Mitra J., Guo W., Guerrero E.N. et al. . (2019) RT2 PCR array screening reveals distinct perturbations in DNA damage response signaling in FUS-associated motor neuron disease. Mol. Brain 12, 103 10.1186/s13041-019-0526-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-019-0526-4</ArticleId><ArticleId IdType="pmc">PMC6894127</ArticleId><ArticleId IdType="pubmed">31801573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Guo W., Mitra J., Hegde P.M., Vandoorne T., Eckelmann B.J. et al. . (2018) Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis. Nat. Commun. 9, 3683 10.1038/s41467-018-06111-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06111-6</ArticleId><ArticleId IdType="pmc">PMC6134028</ArticleId><ArticleId IdType="pubmed">30206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A. et al. . (2018) Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 9, 335 10.1038/s41467-017-02299-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller K.M., Tjeertes J.V., Coates J., Legube G., Polo S.E., Britton S. et al. . (2010) Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat. Struct. Mol. Biol. 17, 1144&#x2013;1151 10.1038/nsmb.1899</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1899</ArticleId><ArticleId IdType="pmc">PMC3018776</ArticleId><ArticleId IdType="pubmed">20802485</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong J., Huang M., Wang F., Ma X., Liu H., Tu Y. et al. . (2017) RBM45 competes with HDAC1 for binding to FUS in response to DNA damage. Nucleic Acids Res. 45, 12862&#x2013;12876 10.1093/nar/gkx1102</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1102</ArticleId><ArticleId IdType="pmc">PMC5728411</ArticleId><ArticleId IdType="pubmed">29140459</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuuluvainen L., Kaivola K., M&#xf6;nk&#xe4;re S., Laaksovirta H., Jokela M., Udd B. et al. . (2019) Oligogenic basis of sporadic ALS: The example of SOD1 p.Ala90Val mutation. Neurol. Genet. 5, e335 10.1212/NXG.0000000000000335</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000335</ArticleId><ArticleId IdType="pmc">PMC6481226</ArticleId><ArticleId IdType="pubmed">31086828</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulson H. (2018) Handbook of Clinical Neurology. Handb Clin. Neurol. 147, 105&#x2013;123 10.1016/B978-0-444-63233-3.00009-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63233-3.00009-9</ArticleId><ArticleId IdType="pmc">PMC6485936</ArticleId><ArticleId IdType="pubmed">29325606</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X.-N. and Usdin K. (2015) The Repeat Expansion Diseases: The dark side of DNA repair. DNA Repair (Amst.) 32, 96&#x2013;105 10.1016/j.dnarep.2015.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2015.04.019</ArticleId><ArticleId IdType="pmc">PMC4522390</ArticleId><ArticleId IdType="pubmed">26002199</ArticleId></ArticleIdList></Reference><Reference><Citation>Mossevelde S.V., van der Zee J., Cruts M. and Broeckhoven C.V. (2017) Relationship between C9orf72 repeat size and clinical phenotype. Curr. Opin. Genet. Dev. 44, 117&#x2013;124 10.1016/j.gde.2017.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2017.02.008</ArticleId><ArticleId IdType="pubmed">28319737</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler A.R., Donnelly C.J., Periz G., Simko E.A.J., Shaw P.G., Kim M.-S. et al. . (2014) C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507, 195&#x2013;200 10.1038/nature13124</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K., Schmidt M.H.M., Geist J.M., Thakkar N.P., Panigrahi G.B., Wang Y.-H. et al. . (2014) Processing of double-R-loops in (CAG)&#xb7;(CTG) and C9orf72 (GGGGCC)&#xb7;(GGCCCC) repeats causes instability. Nucleic Acids Res. 42, 10473&#x2013;10487 10.1093/nar/gku658</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku658</ArticleId><ArticleId IdType="pmc">PMC4176329</ArticleId><ArticleId IdType="pubmed">25147206</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Mizielinska S., Nicoll A.J., Zloh M., Fisher E.M.C., Parkinson G. et al. . (2012) C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci. Rep.-U.K. 2, 1016 10.1038/srep01016</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep01016</ArticleId><ArticleId IdType="pmc">PMC3527825</ArticleId><ArticleId IdType="pubmed">23264878</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K., Zamiri B., Stanley S.Y.R., Macgregor R.B. and Pearson C.E. (2013) The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J. Biol. Chem. 288, 9860&#x2013;9866 10.1074/jbc.C113.452532</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C113.452532</ArticleId><ArticleId IdType="pmc">PMC3617286</ArticleId><ArticleId IdType="pubmed">23423380</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett C.L., Dastidar S.G., Ling S.-C., Malik B., Ashe T., Wadhwa M. et al. . (2018) Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients. Acta Neuropathol. 136, 425&#x2013;443 10.1007/s00401-018-1852-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1852-9</ArticleId><ArticleId IdType="pmc">PMC6098723</ArticleId><ArticleId IdType="pubmed">29725819</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H. and Cleveland D.W. (2016) Decoding ALS: from genes to mechanism. Nature 539, 197&#x2013;206 10.1038/nature20413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M.A., Konopka A., Soo K.Y., Ito D. and Atkin J.D. (2017) The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in Amyotrophic Lateral Sclerosis. Hum. Mol. Genet. 26, 2882&#x2013;2896 10.1093/hmg/ddx170</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx170</ArticleId><ArticleId IdType="pubmed">28481984</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S., Gascon E., Tran H., Chou H.J., Gendron T.F., Degroot S. et al. . (2013) Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 126, 385&#x2013;399 10.1007/s00401-013-1149-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1149-y</ArticleId><ArticleId IdType="pmc">PMC3753484</ArticleId><ArticleId IdType="pubmed">23836290</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly C.J., Zhang P.-W., Pham J.T., Haeusler A.R., Heusler A.R., Mistry N.A. et al. . (2013) RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80, 415&#x2013;428 10.1016/j.neuron.2013.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Baughn M., Rigo F., Sun S., Liu P., Li H.-R. et al. . (2013) Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. U.S.A. 110, E4530&#x2013;E4539 10.1073/pnas.1318835110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318835110</ArticleId><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-B., Chen H.-J., Peres J.N., Gomez-Deza J., Attig J., Stalekar M. et al. . (2013) Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 5, 1178&#x2013;1186 10.1016/j.celrep.2013.10.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Lashley T., Norona F.E., Clayton E.L., Ridler C.E., Fratta P. et al. . (2013) C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol. 126, 845&#x2013;857 10.1007/s00401-013-1200-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1200-z</ArticleId><ArticleId IdType="pmc">PMC3830745</ArticleId><ArticleId IdType="pubmed">24170096</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Walsh M.J., Higginbottom A., Highley J.R., Dickman M.J., Edbauer D. et al. . (2014) Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain 137, 2040&#x2013;2051 10.1093/brain/awu120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon E.G., Lu L., Sharma A., Yamazaki T., Tang T., Shneider N.A. et al. . (2016) The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. Elife 5, e17820 10.7554/eLife.17820</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.17820</ArticleId><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon E.G., Fagegaltier D., Agius P., Davis-Porada J., Gregory J., Hubbard I. et al. . (2018) Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism. Elife 7, e37754 10.7554/eLife.37754</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.37754</ArticleId><ArticleId IdType="pmc">PMC6103746</ArticleId><ArticleId IdType="pubmed">30003873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E.A., Bieniek K.F., Gendron T.F., Caulfield T., Lin W.-L., Dejesus-Hernandez M. et al. . (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77, 639&#x2013;646 10.1016/j.neuron.2013.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Bieniek K.F., Zhang Y.-J., Jansen-West K., Ash P.E.A., Caulfield T. et al. . (2013) Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 126, 829&#x2013;844 10.1007/s00401-013-1192-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Weng S.-M., Arzberger T., May S., Rentzsch K., Kremmer E. et al. . (2013) The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS. Science 339, 1335&#x2013;1338 10.1126/science.1232927</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T., Liu Y., Banez-Coronel M., Reid T., Pletnikova O., Lewis J. et al. . (2013) RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. 110, E4968&#x2013;E4977 10.1073/pnas.1315438110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T.F., Karydas A., Tran H., Yang D. et al. . (2016) Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons. Neuron 92, 383&#x2013;391 10.1016/j.neuron.2016.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon D.A., Stepto A., Au W.H., Adachi Y., Diaper D.C., Hall R. et al. . (2018) A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-&#x3b1; mediates C9orf72-related neurodegeneration. Brain 141, 2908&#x2013;2924 10.1093/brain/awy241</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy241</ArticleId><ArticleId IdType="pmc">PMC6158706</ArticleId><ArticleId IdType="pubmed">30239641</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihei Y., Mori K., Werner G., Arzberger T., Degeneration GC for FL, Alliance BBB et al. . (2019) Poly-glycine-alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3. Acta Neuropathol. 139, 99&#x2013;118 10.1007/s00401-019-02082-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02082-0</ArticleId><ArticleId IdType="pmc">PMC6942035</ArticleId><ArticleId IdType="pubmed">31642962</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Lu Y., Lopez-Gonzalez R., Kim N.C., Almeida S., Lee K.-H. et al. . (2015) GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525, 129&#x2013;133 10.1038/nature14974</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A., Mertens J., Boeynaems S., Bogaert E., Chai N., Yamada S.B. et al. . (2015) Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 18, 1226&#x2013;1229 10.1038/nn.4085</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C.-Z., Spektor A., Cornils H., Francis J.M., Jackson E.K., Liu S. et al. . (2015) Chromothripsis from DNA damage in micronuclei. Nature 522, 179&#x2013;184 10.1038/nature14493</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14493</ArticleId><ArticleId IdType="pmc">PMC4742237</ArticleId><ArticleId IdType="pubmed">26017310</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-J., Guo L., Gonzales P.K., Gendron T.F., Wu Y., Jansen-West K. et al. . (2019) Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science 363, eaav2606 10.1126/science.aav2606</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav2606</ArticleId><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M., Pfister V., Gaucherot A., Ruffenach F., Negroni L., Sellier C. et al. . (2020) Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J. 39, e100574 10.15252/embj.2018100574</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018100574</ArticleId><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C., Herranz-Martin S., Karyka E., Liao C., Lewis K., Elsayed W. et al. . (2017) C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat. Neurosci. 20, 1225&#x2013;1235 10.1038/nn.4604</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4604</ArticleId><ArticleId IdType="pmc">PMC5578434</ArticleId><ArticleId IdType="pubmed">28714954</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Yang D., Pribadi M., Kim T.S., Krishnan G., Choi S.Y. et al. . (2019) Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in C9ORF72 -ALS/FTD. Proc. Natl. Acad. Sci. 116, 9628&#x2013;9633 10.1073/pnas.1901313116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1901313116</ArticleId><ArticleId IdType="pmc">PMC6511021</ArticleId><ArticleId IdType="pubmed">31019093</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmus G., Pilger D., Coates J., Demir M., Sczaniecka-Clift M., Barros A.C. et al. . (2019) ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks. Nat. Commun. 10, 87 10.1038/s41467-018-07729-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07729-2</ArticleId><ArticleId IdType="pmc">PMC6325118</ArticleId><ArticleId IdType="pubmed">30622252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer N.J., Haney M.S., Morgens D.W., Jovi&#x10d;i&#x107; A., Couthouis J., Li A. et al. . (2018) CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nat. Genet. 50, 603&#x2013;612 10.1038/s41588-018-0070-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0070-7</ArticleId><ArticleId IdType="pmc">PMC5893388</ArticleId><ArticleId IdType="pubmed">29507424</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinant C. and Luijsterburg M.S. (2009) The Emerging Role of HP1 in the DNA Damage Response. Mol. Cell. Biol. 29, 6335&#x2013;6340 10.1128/MCB.01048-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01048-09</ArticleId><ArticleId IdType="pmc">PMC2786877</ArticleId><ArticleId IdType="pubmed">19805510</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Jiang X., Xu Y., Ayrapetov M.K., Moreau L.A., Whetstine J.R. et al. . (2009) Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60. Nat. Cell Biol. 11, 1376&#x2013;1382 10.1038/ncb1982</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1982</ArticleId><ArticleId IdType="pmc">PMC2783526</ArticleId><ArticleId IdType="pubmed">19783983</ArticleId></ArticleIdList></Reference><Reference><Citation>Earle A.J., Kirby T.J., Fedorchak G.R., Isermann P., Patel J., Iruvanti S. et al. . (2019) Mutant lamins cause nuclear envelope rupture and DNA damage in skeletal muscle cells. Nat. Mater. 19, 464&#x2013;473 10.1038/s41563-019-0563-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41563-019-0563-5</ArticleId><ArticleId IdType="pmc">PMC7102937</ArticleId><ArticleId IdType="pubmed">31844279</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B., Bardai F.H. and Feany M.B. (2016) Lamin Dysfunction Mediates Neurodegeneration in Tauopathies. Curr. Biol. 26, 129&#x2013;136 10.1016/j.cub.2015.11.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2015.11.039</ArticleId><ArticleId IdType="pmc">PMC4713335</ArticleId><ArticleId IdType="pubmed">26725200</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y., Wang J., Henderson M.J., Yang P., Hagen B.M., Siddique T. et al. . (2017) Nuclear export of misfolded SOD1 mediated by a normally buried NES-like sequence reduces proteotoxicity in the nucleus. ELife e23759 10.7554/eLife.23759</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.23759</ArticleId><ArticleId IdType="pmc">PMC5449186</ArticleId><ArticleId IdType="pubmed">28463106</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Angelo M.A., Raices M., Panowski S.H. and Hetzer M.W. (2009) Age-Dependent Deterioration of Nuclear Pore Complexes Causes a Loss of Nuclear Integrity in Postmitotic Cells. Cell 136, 284&#x2013;295 10.1016/j.cell.2008.11.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.11.037</ArticleId><ArticleId IdType="pmc">PMC2805151</ArticleId><ArticleId IdType="pubmed">19167330</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukata L., Parker S.L. and D'Angelo M.A. (2013) Nuclear pore complexes in the maintenance of genome integrity. Curr. Opin. Cell Biol. 25, 378&#x2013;386 10.1016/j.ceb.2013.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2013.03.002</ArticleId><ArticleId IdType="pubmed">23567027</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauer M.H. and Gasser S.M. (2017) Chromatin and nucleosome dynamics in DNA damage and repair. Gene. Dev. 31, 2204&#x2013;2221 10.1101/gad.307702.117</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.307702.117</ArticleId><ArticleId IdType="pmc">PMC5769766</ArticleId><ArticleId IdType="pubmed">29284710</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T. and Robberecht W. (2011) Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 10, 253&#x2013;263 10.1016/S1474-4422(11)70015-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanisch U.-K. and Kettenmann H. (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387&#x2013;1394 10.1038/nn1997</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1997</ArticleId><ArticleId IdType="pubmed">17965659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A. and Locati M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677&#x2013;686 10.1016/j.it.2004.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2004.09.015</ArticleId><ArticleId IdType="pubmed">15530839</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Wu J., Du F., Chen X. and Chen Z.J. (2012) Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway. Science 339, 786&#x2013;791 10.1126/science.1232458</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232458</ArticleId><ArticleId IdType="pmc">PMC3863629</ArticleId><ArticleId IdType="pubmed">23258413</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T. and Chen Z.J. (2018) The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J. Exp. Med. 215, 1287&#x2013;1299 10.1084/jem.20180139</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20180139</ArticleId><ArticleId IdType="pmc">PMC5940270</ArticleId><ArticleId IdType="pubmed">29622565</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y. and Chen Z.J. (2012) STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 5, ra20 10.1126/scisignal.2002521</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2002521</ArticleId><ArticleId IdType="pmc">PMC3549669</ArticleId><ArticleId IdType="pubmed">22394562</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Bieniek K.F., Finch N., van de Vorst M., Baker M., Perkersen R. et al. . (2015) Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 130, 77&#x2013;92 10.1007/s00401-015-1436-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1436-x</ArticleId><ArticleId IdType="pmc">PMC4470809</ArticleId><ArticleId IdType="pubmed">25943890</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., M&#xfc;ller K. et al. . (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 18, 631&#x2013;636 10.1038/nn.4000</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Basit A., Cho M.-G., Kim E.-Y., Kwon D., Kang S.-J. and Lee J.-H. (2020) The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels. Exp. Mol. Med. 52, 643&#x2013;657 10.1038/s12276-020-0416-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-020-0416-y</ArticleId><ArticleId IdType="pmc">PMC7210884</ArticleId><ArticleId IdType="pubmed">32284536</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug L., Chatterjee N., Borges-Monroy R., Hearn S., Liao W.-W., Morrill K. et al. . (2017) Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. PLos Genet. 13, e1006635 10.1371/journal.pgen.1006635</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006635</ArticleId><ArticleId IdType="pmc">PMC5354250</ArticleId><ArticleId IdType="pubmed">28301478</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y.-H. and Dubnau J. (2019) The Gypsy Endogenous Retrovirus Drives Non-Cell-Autonomous Propagation in a Drosophila TDP-43 Model of Neurodegeneration. Curr. Biol. Cb 29, 3135.e4&#x2013;3152.e4 10.1016/j.cub.2019.07.071</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2019.07.071</ArticleId><ArticleId IdType="pmc">PMC6783360</ArticleId><ArticleId IdType="pubmed">31495585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace N.A., Belancio V.P. and Deininger P.L. (2008) L1 mobile element expression causes multiple types of toxicity. Gene 419, 75&#x2013;81 10.1016/j.gene.2008.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2008.04.013</ArticleId><ArticleId IdType="pmc">PMC3760205</ArticleId><ArticleId IdType="pubmed">18555620</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K. and Komine O. (2018) The multi-dimensional roles of astrocytes in ALS. Neurosci. Res. 126, 31&#x2013;38 10.1016/j.neures.2017.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostalski H., Leskel&#xe4; S., Huber N., Katisko K., Cajanus A., Solje E. et al. . (2019) Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS. Front. Neurosci.-Switz 13, 486 10.3389/fnins.2019.00486</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00486</ArticleId><ArticleId IdType="pmc">PMC6529740</ArticleId><ArticleId IdType="pubmed">31156371</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M., Harlan B.A., Killoy K.M. and Vargas M.R. (2018) Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis. Curr. Pharm. Design 23, 10.2174/1381612823666170622095802</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170622095802</ArticleId><ArticleId IdType="pmc">PMC5740017</ArticleId><ArticleId IdType="pubmed">28641533</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B. et al. . (2008) TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science 319, 1668&#x2013;1672 10.1126/science.1154584</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D.A., LeClerc A.L., Tamrazian E., Vanderburg C.R., Russ C. et al. . (2009) Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis. Science 323, 1205&#x2013;1208 10.1126/science.1166066</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H. and Hegde M.L. (2019) New Mechanisms of DNA Repair Defects in Fused in Sarcoma-Associated Neurodegeneration: Stage Set for DNA Repair-Based Therapeutics? J. Exp. Neurosci. 13, 1&#x2013;5 10.1177/1179069519856358</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179069519856358</ArticleId><ArticleId IdType="pmc">PMC6558540</ArticleId><ArticleId IdType="pubmed">31217692</ArticleId></ArticleIdList></Reference><Reference><Citation>Appocher C., Mohagheghi F., Cappelli S., Stuani C., Romano M., Feiguin F. et al. . (2017) Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. Nucleic Acids Res. 45, gkx477 10.1093/nar/gkx477</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx477</ArticleId><ArticleId IdType="pmc">PMC5570092</ArticleId><ArticleId IdType="pubmed">28575377</ArticleId></ArticleIdList></Reference><Reference><Citation>Gittings L.M., Foti S.C., Benson B.C., Gami-Patel P., Isaacs A.M. and Lashley T. (2019) Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS. Acta Neuropathol. Commun. 7, 18 10.1186/s40478-019-0673-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0673-y</ArticleId><ArticleId IdType="pmc">PMC6371513</ArticleId><ArticleId IdType="pubmed">30755280</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley B., Paunesku T., Proti&#x107; M. and Woloschak G.E. (2009) Response of heterogeneous ribonuclear proteins (hnRNP) to ionising radiation and their involvement in DNA damage repair. Int. J. Radiat. Biol. 85, 643&#x2013;655 10.1080/09553000903009548</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09553000903009548</ArticleId><ArticleId IdType="pmc">PMC2785495</ArticleId><ArticleId IdType="pubmed">19579069</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W., Lei L., Xie X., Huang L., Cui Q., Dang T. et al. . (2019) Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer. Cell Death. Dis. 10, 550 10.1038/s41419-019-1784-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1784-x</ArticleId><ArticleId IdType="pmc">PMC6639419</ArticleId><ArticleId IdType="pubmed">31320608</ArticleId></ArticleIdList></Reference><Reference><Citation>Geuens T., Bouhy D. and Timmerman V. (2016) The hnRNP family: insights into their role in health and disease. Hum. Genet. 135, 851&#x2013;867 10.1007/s00439-016-1683-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-016-1683-5</ArticleId><ArticleId IdType="pmc">PMC4947485</ArticleId><ArticleId IdType="pubmed">27215579</ArticleId></ArticleIdList></Reference><Reference><Citation>Decorsi&#xe8;re A., Cayrel A., Vagner S. and Millevoi S. (2011) Essential role for the interaction between hnRNP H/F and a G quadruplex in maintaining p53 pre-mRNA 3&#x2032;-end processing and function during DNA damage. Gene Dev. 25, 220&#x2013;225 10.1101/gad.607011</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.607011</ArticleId><ArticleId IdType="pmc">PMC3034896</ArticleId><ArticleId IdType="pubmed">21289067</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A. and Traynor B.J. (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 17, 94&#x2013;102 10.1016/S1474-4422(17)30401-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui J., Lin Y.-F., Xu K., Lee K.-J., Wang D. and Chen B.P.C. (2015) DNA-PKcs phosphorylates hnRNP-A1 to facilitate the RPA-to-POT1 switch and telomere capping after replication. Nucleic Acids Res. 43, 5971&#x2013;5983 10.1093/nar/gkv539</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv539</ArticleId><ArticleId IdType="pmc">PMC4499152</ArticleId><ArticleId IdType="pubmed">25999341</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshaies J.-E., Shkreta L., Moszczynski A.J., Sidib&#xe9; H., Semmler S., Fouillen A. et al. . (2018) TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain 141, 1320&#x2013;1333 10.1093/brain/awy062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy062</ArticleId><ArticleId IdType="pmc">PMC5917749</ArticleId><ArticleId IdType="pubmed">29562314</ArticleId></ArticleIdList></Reference><Reference><Citation>Registry P., Group S., Registry S., Consortium F.S., Consortium S., Group N.S. et al. . (2016) Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 48, 1043&#x2013;1048</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.A., Lin Z., Kim E., Henstridge C.M., Altamira E.P., Hunt C.K. et al. . (2019) Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss. Acta Neuropathol. Commun. 7, 166 10.1186/s40478-019-0800-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0800-9</ArticleId><ArticleId IdType="pmc">PMC6819591</ArticleId><ArticleId IdType="pubmed">31661035</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsukawa K., Hashimoto T., Matsumoto T., Ihara R., Chihara T., Miura M. et al. . (2016) Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43. J. Biol. Chem. 291, 23464&#x2013;23476 10.1074/jbc.M116.729152</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.729152</ArticleId><ArticleId IdType="pmc">PMC5095402</ArticleId><ArticleId IdType="pubmed">27634045</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.-X., Chen W., Hong S.-T., Boycott K.M., Gorrie G.H., Siddique N. et al. . (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477, 211&#x2013;215 10.1038/nature10353</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud L., Picher-Martel V., Codron P. and Julien J.-P. (2019) Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol. Commun. 7, 103 10.1186/s40478-019-0758-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0758-7</ArticleId><ArticleId IdType="pmc">PMC6889556</ArticleId><ArticleId IdType="pubmed">31319884</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K.L., Topp S., Yang S., Smith B., Fifita J.A., Warraich S.T. et al. . (2016) CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat. Commun. 7, 11253 10.1038/ncomms11253</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11253</ArticleId><ArticleId IdType="pmc">PMC4835537</ArticleId><ArticleId IdType="pubmed">27080313</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y., Uchino A., Shioya A., Sano T., Matsumoto C., Numata&#x2010;Uematsu Y. et al. . (2019) Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS. Neuropathology 39, 268&#x2013;278 10.1111/neup.12558</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12558</ArticleId><ArticleId IdType="pmc">PMC6852233</ArticleId><ArticleId IdType="pubmed">31124187</ArticleId></ArticleIdList></Reference><Reference><Citation>Icli B., Bharti A., Pentassuglia L., Peng X. and Sawyer D.B. (2012) ErbB4 localization to cardiac myocyte nuclei, and its role in myocyte DNA damage response. Biochem. Bioph. Res. Commun. 418, 116&#x2013;121 10.1016/j.bbrc.2011.12.144</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2011.12.144</ArticleId><ArticleId IdType="pmc">PMC3273580</ArticleId><ArticleId IdType="pubmed">22244893</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmore-Hebert M., Ramabhadran R. and Stern D.F. (2010) Interactions of ErbB4 and Kap1 Connect the Growth Factor and DNA Damage Response Pathways. Mol. Cancer Res. 8, 1388&#x2013;1398 10.1158/1541-7786.MCR-10-0042</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-10-0042</ArticleId><ArticleId IdType="pmc">PMC3901583</ArticleId><ArticleId IdType="pubmed">20858735</ArticleId></ArticleIdList></Reference><Reference><Citation>Arasada R.R. and Carpenter G. (2005) Secretase-dependent Tyrosine Phosphorylation of Mdm2 by the ErbB-4 Intracellular Domain Fragment. J. Biol. Chem. 280, 30783&#x2013;30787 10.1074/jbc.M506057200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M506057200</ArticleId><ArticleId IdType="pubmed">15985438</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukunaga K., Shinoda Y. and Tagashira H. (2015) The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis. J. Pharmacol. Sci. 127, 36&#x2013;41 10.1016/j.jphs.2014.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphs.2014.12.012</ArticleId><ArticleId IdType="pubmed">25704016</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneb H.M., Folkmann A.W., Belzil V.V., Jao L.-E., Leblond C.S., Girard S.L. et al. . (2015) Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis. Hum. Mol. Genet. 24, 1363&#x2013;1373 10.1093/hmg/ddu545</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu545</ArticleId><ArticleId IdType="pmc">PMC4321443</ArticleId><ArticleId IdType="pubmed">25343993</ArticleId></ArticleIdList></Reference><Reference><Citation>Aditi X.X.X., Glass L., Dawson T.R. and Wente S.R. (2016) An amyotrophic lateral sclerosis-linked mutation in GLE1 alters the cellular pool of human Gle1 functional isoforms. Adv. Biological Regul. 62, 25&#x2013;36 10.1016/j.jbior.2015.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2015.11.001</ArticleId><ArticleId IdType="pmc">PMC4864155</ArticleId><ArticleId IdType="pubmed">26776475</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamura M., Yamanaka Y., Shigemoto M., Kitadani Y., Kobayashi Y., Kambe T. et al. . (2018) Depletion of mRNA export regulator DBP5/DDX19, GLE1 or IPPK that is a key enzyme for the production of IP6, resulting in differentially altered cytoplasmic mRNA expression and specific cell defect. PLoS ONE 13, e0197165 10.1371/journal.pone.0197165</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0197165</ArticleId><ArticleId IdType="pmc">PMC5945018</ArticleId><ArticleId IdType="pubmed">29746542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni M., Pansarasa O., Dell'Orco M., Crippa V., Gagliardi S., Sproviero D. et al. . (2019) Nuclear Phospho-SOD1 Protects DNA from Oxidative Stress Damage in Amyotrophic Lateral Sclerosis. J. Clin. Med. 8, 729 10.3390/jcm8050729</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8050729</ArticleId><ArticleId IdType="pmc">PMC6572067</ArticleId><ArticleId IdType="pubmed">31121901</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondori N.R., Paul P., Robbins J.P., Liu K., Hildyard J.C.W., Wells D.J. et al. . (2018) Focus on the Role of D-serine and D-amino Acid Oxidase in Amyotrophic Lateral Sclerosis/Motor Neuron Disease (ALS). Front. Mol. Biosci. 5, 8 10.3389/fmolb.2018.00008</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2018.00008</ArticleId><ArticleId IdType="pmc">PMC5816792</ArticleId><ArticleId IdType="pubmed">29487852</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H., Lin X., Xie C., Laird F.M., Lai C., Wen H. et al. . (2005) Loss of ALS2 Function Is Insufficient to Trigger Motor Neuron Degeneration in Knock-Out Mice But Predisposes Neurons to Oxidative Stress. J. Neurosci. 25, 7567&#x2013;7574 10.1523/JNEUROSCI.1645-05.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1645-05.2005</ArticleId><ArticleId IdType="pmc">PMC2364727</ArticleId><ArticleId IdType="pubmed">16107644</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., Jara J.H., Sekerkova G., Yasvoina M.V., Martina M. and &#xd6;zdinler P.H. (2016) Absence of alsin function leads to corticospinal motor neuron vulnerability via novel disease mechanisms. Hum. Mol. Genet. 25, 1074&#x2013;1087 10.1093/hmg/ddv631</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv631</ArticleId><ArticleId IdType="pmc">PMC4764190</ArticleId><ArticleId IdType="pubmed">26755825</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka A. and Atkin J. (2018) The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 19, 3137 10.3390/ijms19103137</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19103137</ArticleId><ArticleId IdType="pmc">PMC6213462</ArticleId><ArticleId IdType="pubmed">30322030</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripolszki K., T&#xf6;r&#xf6;k D., Gouden&#xe8;ge D., Farkas K., Sul&#xe1;k A., T&#xf6;r&#xf6;k N. et al. . (2017) High&#x2010;throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis. Brain Behav. 7, e00669 10.1002/brb3.669</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.669</ArticleId><ArticleId IdType="pmc">PMC5390843</ArticleId><ArticleId IdType="pubmed">28413711</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-Z., Bennett C.L., Huynh H.M., Blair I.P., Puls I., Irobi J. et al. . (2004) DNA/RNA Helicase Gene Mutations in a Form of Juvenile Amyotrophic Lateral Sclerosis (ALS4). Am. J. Hum Genet. 74, 1128&#x2013;1135 10.1086/421054</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421054</ArticleId><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero W., Shatunov A., Stahl D., Shoai M., van Rheenen W., Jones A.R. et al. . (2017) ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol. Aging 51, 178.e1&#x2013;178.e9 10.1016/j.neurobiolaging.2016.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.11.010</ArticleId><ArticleId IdType="pmc">PMC5302215</ArticleId><ArticleId IdType="pubmed">28017481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao D.Y., Gish G., Braunschweig U., Li Y., Ni Z., Schmitges F.W. et al. . (2016) SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination. Nature 529, 48&#x2013;53 10.1038/nature16469</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature16469</ArticleId><ArticleId IdType="pubmed">26700805</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M., van Blitterswijk M.M., Vlam L., Rowicka P.A., van Vught P.W.J., Groen E.J.N. et al. . (2012) VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 33, 837.e7&#x2013;837.e13 10.1016/j.neurobiolaging.2011.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.006</ArticleId><ArticleId IdType="pubmed">22078486</ArticleId></ArticleIdList></Reference><Reference><Citation>Acs K., Luijsterburg M.S., Ackermann L., Salomons F.A., Hoppe T. and Dantuma N.P. (2011) The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks. Nat. Struct. Mol. Biol. 18, 1345&#x2013;1350 10.1038/nsmb.2188</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2188</ArticleId><ArticleId IdType="pubmed">22120668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayaki T., Ito H., Fukushima H., Inoue T., Kondo T., Ikemoto A. et al. . (2014) Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant. Acta Neuropathol. Commun. 2, 172 10.1186/s40478-014-0172-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0172-0</ArticleId><ArticleId IdType="pmc">PMC4297454</ArticleId><ArticleId IdType="pubmed">25492614</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J., Catanese A., Semelink-Sedlacek L.L., Oeztuerk S., Lutz A.-K., Bausinger J. et al. . (2018) NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res. 30, 150&#x2013;162 10.1016/j.scr.2018.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.06.005</ArticleId><ArticleId IdType="pubmed">29929116</ArticleId></ArticleIdList></Reference><Reference><Citation>Salton M., Lerenthal Y., Wang S.-Y., Chen D.J. and Shiloh Y. (2010) Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle 9, 1568&#x2013;1576 10.4161/cc.9.8.11298</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.9.8.11298</ArticleId><ArticleId IdType="pubmed">20421735</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhu W.-G. and Zhao Y. (2016) Autophagy substrate SQSTM1/p62 regulates chromatin ubiquitination during the DNA damage response. Autophagy 13, 212&#x2013;213 10.1080/15548627.2016.1245262</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1245262</ArticleId><ArticleId IdType="pmc">PMC5240823</ArticleId><ArticleId IdType="pubmed">27791533</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes J.A., Davies M.C. and Collins M.O. (2017) TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol. Brain 10, 5 10.1186/s13041-017-0287-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0287-x</ArticleId><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Fazly A.M., Zhou H., Huang S., Zhang Z. and Stillman B. (2009) The Elongator Complex Interacts with PCNA and Modulates Transcriptional Silencing and Sensitivity to DNA Damage Agents. PLos Genet. 5, e1000684 10.1371/journal.pgen.1000684</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000684</ArticleId><ArticleId IdType="pmc">PMC2757915</ArticleId><ArticleId IdType="pubmed">19834596</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Mu&#xf1;oz M.D., Kiselev V.Y.U., Nov&#xe8;re N.L., Curk T., Ule J. and Turner M. (2017) Tia1 dependent regulation of mRNA subcellular location and translation controls p53 expression in B cells. Nat. Commun. 8, 530 10.1038/s41467-017-00454-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00454-2</ArticleId><ArticleId IdType="pmc">PMC5597594</ArticleId><ArticleId IdType="pubmed">28904350</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>